We have identified two single nucleotide polymorphisms and one dinucleotide microsatellite within the promoter region of the interferon-␣ receptor gene (IFNAR, GenBank accession number X60459). Allele frequencies in a Caucasian population were established using PCR-RFLP for the two SNPs and semi-automated genotyping for the microsatellite. Genes and Immunity (2001) 2, 159-160.
Type I interferons are cytokines originally identified by their ability to generate a rapid, non-specific, anti-viral response. Although they are capable of differing levels of expression all Type I interferons interact with the same cell surface receptor, IFNAR. The interferon-␣ receptor is composed of two subunits 1,2 as has been described for several other cytokine receptor systems. The 557 amino acid precursor gives rise to a 530 amino acid mature protein which is present in low copy numbers on almost all cell types. 1 The human IFNAR gene has been mapped to chromosome 21q22.1 3 and covers approximately 33 kb, containing 11 exons and 10 introns.
This study found two novel SNPs within the downstream promoter region of the interferon-␣ receptor. A C/T SNP was identified at −408 base pairs relative to the start of transcription (5ЈGCGAC C/T AGGAG 3Ј) and a G to A substitution was identified at position −18 (5ЈGCTAA G/A AGGGG 3Ј). The mutant alleles were found to occur at a frequency of 30% and 35%, respectively, in healthy UK Caucasians (see Table 1a ). Evidence for linkage disequilibrium (D = 0.4) was found between −408C and −18A and between −408T and −18G.
Sequencing revealed a GT repeat microsatellite starting at position −77 relative to the start of transcription. Variations of between five and 13 repeats were identified. The published sequence (Genbank accession number X60459) shows the rarer 265-bp allele with nine GT repeats which we have designated allele 105:
The microsatellite allele frequencies were investigated in a healthy UK Caucasian population, the results are presented in Evidence for linkage disequilibrium was found between −18G and allele 101 (D = 0.486).
The effect of these polymorphisms on transcription factor binding sites within the promoter region was investigated using the Matinspector v2.2 sequence analysis program. 4 Neither the SNPs nor the microsatellite polymorphisms mapped to any recognised promoter elements.
We have identified novel polymorphisms within the promoter region of the interferon-␣ receptor. The position of these polymorphisms may affect levels of expression of the mature protein, leading to variation in response to Type I interferons. These cytokines have a central role in both viral infection and malignant diseases and interferon-␣ is used as a treatment in conditions such as chronic viral hepatitis and leukaemia. It is possible that these polymorphisms may serve as useful markers for disease susceptibility and response and expand our understanding of the role of interferons in disease. An 854-bp fragment containing the region upstream of the start of transcription of the IFNAR1 gene was amplified using PCR primers 5Ј TCT CGC CCC TCA GCC AAG TC 3Ј, starting at position −629 and 5Ј CAG CTG CGT GCC CTA CCT CC 3Ј, starting at position +205. PCR reactions were carried out in a final volume of 25 l, containing 50 ng genomic DNA, 10× KCl buffer (including 1.5 mm MgCl 2 , 0.2 mm each of dNTP's (Bioline), 5 pM of each primer, 1 unit taq polymerase (Bioline, London, UK). PCR cycles of 95°C for 2 min, followed by 35 cycles of 95°C for 40 s, 61°C for 40 s and 72°C for 60 s and a final extension step of 72°C for 2 min. All PCR reactions were performed on Hybaid (Omnigene, Ashford, UK) machines and Peltier PTC-225 Thermal cyclers in 96 well microtitre plates and PCR products were visualised on 1% agarose gels stained with ethidium bromide. PCR products were studied for polymorphisms by single-strand conformational polymorphism (SSCP), using 6% acrylamide gels, samples showing variation in banding patterns were sequenced in both directions using a dye terminator cycle sequencing kit (Applied Biosystems, Foster City, CA, USA). DNA samples from healthy UK Caucasian blood donors were used to establish control allele and genotype frequencies. Samples were genotyped for the −18G/A SNP by restriction fragment length polymorphism (RFLP). A 265-bp fragment encompassing the SNP was amplified using primers: Forward 5Ј-GTA GGC CGG AAA GAG TGA GG-3Ј (starting at position −245) and Reverse 5Ј-CTA AGT CAC ACC GCC CCT CT-3Ј (starting at position +1) in a PCR reaction as described above. Restriction fragments were generated by digestion with the endonuclease DdeI (Boehringer Mannheim, Mannheim, Germany). RFLP of the −408 C/T SNP involved amplification of a 328-bp fragment using the following primers: Forward 5Ј TCT CGC CCC TCA GCC AAG TC 3Ј (starting at position −629) and Reverse 5Ј CCT TGA CCT TCA CAG GAT CG 3Ј (starting at position −322) in a PCR reaction as described above. This was followed by digestion with EcoRII (MBI Fermentas, Sunderland, UK). Semi-automated genotyping of IFNAR1 microsatellite was performed using an ABI 377 DNA Sequencer (Applied Biosystems). The same primers as described for amplification of the −18G/A SNP were used with the modification that the forward PCR primers were fluorescence-labelled with 6-FAM at the 5Ј end. Allele sizes, expressed as mobility units, were measured using RO× 400 size standards (Applied Biosystems) and analysed using Genescan 3.1 and Genotyper v2 (Applied Biosystems) software. Control allele and genotype frequencies were tested for Hardy-Weinberg equilibrium using STATAv6 software. EH software 5 was used to calculate disequilibrium (D) values between the markers. Effects of promoter polymorphisms were investigated using sequence analysis software (Matinspector v2.2 4 ) which is able to search a given sequence for matches to a large library of transcription factor binding sites.
